Taiwan FDA registration 2ed310610c5a5fdc71c7f885999266bf

Ashbo Test System (blood glucose, uric acid, total cholesterol)

TW: 艾士博測試系統(血糖、尿酸、總膽固醇)

Taiwan·Risk Class 2·Taibo Technology Co., Ltd. five-stock factory·Registered Mar 22, 2022 – Mar 22, 2027Active

Registration details

Analysis ID: 2ed310610c5a5fdc71c7f885999266bf

Company information

Manufacturer: Taibo Technology Co., Ltd. five-stock factory
Manufacturer Country: Taiwan, Province of China
Authorized Representative: TAIDOC TECHNOLOGY CORPORATION

Product details

Intended Use: This product is an in vitro diagnostic medical device for professionals to quantitatively detect glucose, uric acid and total cholesterol content in the blood. Glucose measurement is measured using fresh fingertip microvascular whole blood and venous whole blood. Total cholesterol and uric acid are measured using fresh fingertip microvascular whole blood. Not suitable for diagnosis and screening of diseases.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1775 Uric acid testing system;; A.1345 Glucose Test System;; A.1175 Cholesterol (Total) Testing System
Import Information: Domestic

Dates and status

Registration Date: Mar 22, 2022
Expiry Date: Mar 22, 2027

About this record

Access comprehensive regulatory information for Ashbo Test System (blood glucose, uric acid, total cholesterol) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2ed310610c5a5fdc71c7f885999266bf and manufactured by Taibo Technology Co., Ltd. five-stock factory. The authorized representative in Taiwan is TAIDOC TECHNOLOGY CORPORATION.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.